And Faiez Zannad.

We calculated that with a sample of 5400 patients, the analysis would have 91 percent capacity to determine the noninferiority of alogliptin to placebo for the 1.8 and 1.3 margins, with the assumption of a true hazard ratio of justContinue reading… And Faiez Zannad.

The federally funded.

BMS is the last major AIDS drug manufacturer to announce additional special discounts for cash-strapped ADAPs, despite the fact that the crisis is now so severe, 2718 individuals in thirteen claims are on waiting lists to receive lifesaving AIDS medicationsContinue reading… The federally funded.

Mohsen Fathzadeh.

Genomic DNA was captured on exomes with the use of the Sequence Capture Individual Exome 2.1M Array . The captured libraries were sequenced on the Illumina Genome Analyzer, and image analysis and base calling had been performed. The resulting sequenceContinue reading… Mohsen Fathzadeh.

Fred Poordad.

A total of 3 patients had a relapse 14 days after treatment, and 8 had a sustained virologic response 12 weeks after treatment . A total of 3 of 7 sufferers with a null response to earlier treatment and 5Continue reading… Fred Poordad.